HCV Reactivation in a Patient with Hepatocellular Carcinoma Due to Sorafenib: A Case Report

HCV Reactivation in a Patient with Hepatocellular Carcinoma Due to Sorafenib: A Case Report

Jun Cheng,* Jinjin Pan,* Dongmei Zhao, Xuejiao Ma, Qiulin Sun, Jiabin Li Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jiabin Li, Tel...

Full description

Bibliographic Details
Main Authors: Cheng J, Pan J, Zhao D, Ma X, Sun Q, Li J
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:International Medical Case Reports Journal
Subjects:
hepatocellular carcinoma
sorafenib
hcv-rna
anti-hcv therapy
reactivation
Online Access:https://www.dovepress.com/hcv-reactivation-in-a-patient-with-hepatocellular-carcinoma-due-to-sor-peer-reviewed-fulltext-article-IMCRJ

Internet

https://www.dovepress.com/hcv-reactivation-in-a-patient-with-hepatocellular-carcinoma-due-to-sor-peer-reviewed-fulltext-article-IMCRJ

Similar Items